Biomarker: W003-IgE Ragweed, Giant

Overview

This biomarker measures allergen-specific immunoglobulin E (IgE) antibodies directed against giant ragweed (Ambrosia trifida) pollen. IgE is an antibody involved in immediate allergic reactions, including seasonal allergic rhinitis, allergic conjunctivitis, and asthma symptoms after pollen exposure. A detectable or elevated result indicates immunologic sensitization to giant ragweed, but does not by itself establish that exposure causes clinical symptoms. The test is clinically useful when interpreted with symptom history, seasonal timing, and exposure patterns to help identify relevant pollen allergens and guide avoidance or allergy treatment decisions.

Clinical Use Cases

Supporting evaluation of suspected giant ragweed-induced seasonal allergic rhinitis.
Assessing patients with seasonal allergic conjunctivitis or asthma symptoms associated with ragweed exposure.
Identifying sensitization when skin testing is unsuitable, unsafe, unavailable, or affected by skin disease or medication use.
Distinguishing sensitization to giant ragweed from sensitization to other weed pollens when species-specific testing is available.
Supporting allergen selection for specialist-directed allergen immunotherapy, alongside clinical history and other allergy-test results.
Investigating possible cross-reactivity among giant ragweed, short ragweed, western ragweed, and mugwort allergens.

Specimen Types

Venous whole blood, with measurement performed on serum.
Serum is the usual specimen for quantitative allergen-specific IgE testing.

Measurement Methods

Fluorescent enzyme immunoassay or other automated solid-phase immunoassay for serum allergen-specific IgE.
Enzyme-linked immunosorbent assay in research applications.
Immunoblotting in research applications for evaluating IgE binding to individual pollen proteins.
Skin-prick or percutaneous testing with giant ragweed pollen extract as an alternative assessment of sensitization, although this is not a measurement of serum W003-specific IgE.

Test Preparation and Influencing Factors

Fasting is generally not required for an allergen-specific IgE blood test.
Patients should report all medications and supplements. Antihistamines can interfere with skin testing, but generally do not prevent measurement of serum-specific IgE.
Medications should not be stopped unless directed by a healthcare professional.
Results should be interpreted with symptoms, exposure history, season, and local pollen patterns because sensitization may occur without clinically relevant allergy.
Cross-reactive IgE antibodies to related ragweed or mugwort pollens may contribute to a positive result and can complicate identification of the primary sensitizing species.
Assay-specific reporting units, detection limits, and classification thresholds vary. Results should be interpreted using the reference information supplied by the testing laboratory and the clinical context.
Total IgE concentration, age, atopic disease, and other immune or medical factors may influence the broader interpretation of IgE testing, but they do not replace allergen-specific assessment.